Form4insider filings, from the source

SEC Form 4 · accession 0001061983-17-000052

CYTOKINETICS INC · CYTK

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Bradley Paul Morgan
Officer — SVP Drug Discovery & Early Dev
Period of report
Aug 31, 2017
Accepted (ET)
Sep 1, 2017 · 7:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001061983

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 31, 2017M16,666$6.67A63,107D
Common StockAug 31, 2017S16,666$15.00D46,441D
Common StockAug 31, 2017M15,206$7.96A61,647D
Common StockAug 31, 2017S15,206$15.00D46,441D
Common StockAug 31, 2017M2,294$7.96A48,735D
Common StockAug 31, 2017S2,294$15.00D46,441D
Common StockAug 31, 2017M11,552$9.65A57,993D
Common StockAug 31, 2017S11,552$15.00D46,441D
Common StockAug 31, 2017M13,448$9.65A59,889D
Common StockAug 31, 2017S13,448$15.00D46,441D
Common StockAug 31, 2017M3,795$6.00A50,236D
Common StockAug 31, 2017S3,795$15.00D46,441D
Common StockAug 31, 2017M21,204$6.00A67,645D
Common StockAug 31, 2017S21,204$15.00D46,441D
Common StockAug 31, 2017M1,079$6.30A47,520D
Common StockAug 31, 2017S1,079$15.00D46,441D
Common StockAug 31, 2017M13,920$6.30A60,361D
Common StockAug 31, 2017S13,920$15.00D46,441D
Common StockAug 31, 2017M617$9.42A47,058D
Common StockAug 31, 2017S617$15.00D46,441D
Common StockAug 31, 2017M11,883$9.42A58,324D
Common StockAug 31, 2017S11,883$15.00D46,441D
Common StockAug 31, 2017M694$11.10A47,135D
Common StockAug 31, 2017S694$15.00D46,441D
Common StockAug 31, 2017M2,639$11.10A49,080D
Common StockAug 31, 2017S2,639$15.00D46,441D
Common StockAug 31, 2017M695$11.10A47,136D
Common StockAug 31, 2017S695$15.00D46,441D
Common StockAug 31, 2017M2,638$11.10A49,079D
Common StockAug 31, 2017S2,638$15.00D46,441D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Incentive Stock Option (right to buy)$6.00Aug 31, 2017M21,204DApr 5, 2013Mar 5, 2023Common Stock21,2040D
Incentive Stock Option (right to buy)$6.30Aug 31, 2017M13,920DApr 5, 2012Mar 5, 2022Common Stock13,9200D
Incentive Stock Option (right to buy)$7.96Aug 31, 2017M2,294DMar 26, 2015Feb 26, 2025Common Stock2,2948,750D
Incentive Stock Option (right to buy)$9.42Aug 31, 2017M11,883DMar 28, 2011Feb 28, 2021Common Stock11,8830D
Incentive Stock Option (right to buy)$9.65Aug 31, 2017M13,448DMar 24, 2014Feb 24, 2024Common Stock13,4485,000D
Incentive Stock Option (right to buy)$11.10Aug 31, 2017M2,639DMar 26, 2009Feb 26, 2019Common Stock2,6392,638D
Incentive Stock Option (right to buy)$11.10Aug 31, 2017M2,638DMar 26, 2009Feb 26, 2019Common Stock2,6380D
Non-Qualified Stock Option (right to buy)$6.00Aug 31, 2017M3,795DApr 5, 2013Mar 5, 2023Common Stock3,7950D
Non-Qualified Stock Option (right to buy)$6.30Aug 31, 2017M1,079DApr 5, 2012Mar 5, 2022Common Stock1,0790D
Non-Qualified Stock Option (right to buy)$6.67Aug 31, 2017M16,666DMar 23, 2016Feb 23, 2026Common Stock16,66614,517D
Non-Qualified Stock Option (right to buy)$7.96Aug 31, 2017M15,206DMar 26, 2015Feb 26, 2025Common Stock15,2063,750D
Non-Qualified Stock Option (right to buy)$9.42Aug 31, 2017M617DMar 28, 2011Feb 28, 2021Common Stock6170D
Non-Qualified Stock Option (right to buy)$9.65Aug 31, 2017M11,552DMar 24, 2014Feb 24, 2024Common Stock11,5520D
Non-Qualified Stock Option (right to buy)$11.10Aug 31, 2017M694DMar 26, 2009Feb 26, 2019Common Stock694695D
Non-Qualified Stock Option (right to buy)$11.10Aug 31, 2017M695DMar 26, 2009Feb 26, 2019Common Stock6950D

Explanation of responses